Joseph Abbandonato Announces Holdings in Imaflex Inc.
SAINTE-ADÈLE, QC, May 9, 2013 /CNW Telbec/ - Joseph Abbandonato ("Mr. Abbandonato" or the "Offeror"), of 3475 Rolland Street, Sainte-Adèle, Québec, J8B 1E1, announces, pursuant to Regulation 62-103 respecting the Early Warning System and Related Take-Over Bid and Insider Reporting Issues ("Regulation 62-103") that he acquired, through a wholly-owned private corporation, Roncon Consultants Inc., ownership of 1,000,000 common shares (each a "Common Share") of Imaflex Inc. ("Imaflex") at a price of $0.50 per Common Share pursuant to a non-brokered private placement (the "private placement") (representing 2.26 % of Imaflex's issued and outstanding Common Shares).
Further to the private placement, Mr. Abbandonato directly owns 10,684,810 Common Shares (representing 24.17 % of the issued and outstanding Common Shares). Mr. Abbandonato directly and indirectly owns, through its wholly-owned company, Roncon Consultants Inc., 13,936,805 Common Shares (representing 31.53 % of the issued and outstanding Common Shares) and 1,973,684 common share purchase warrants of Imaflex (the "Offeror's Warrants") exercisable to acquire 1,973,684 Common Shares. Should the Offeror's Warrants be fully exercised, the Offeror's holdings, both directly and indirectly, would represent 34.46 % of the issued and outstanding Common Shares on a partially diluted basis.
The acquisition of 1,000,000 Common Shares was carried out by way of private placement in accordance with and in reliance on the "Accredited Investor" exemption in section 2.3 of Regulation 45-106 respecting Prospectus and Registration Exemptions.
The securities of Imaflex are held by Mr. Abbandonato for investment purposes. Mr. Abbandonato expects to review from time to time his investment in Imaflex and may, depending on the market and other conditions: (i) acquire securities or related financial instruments of Imaflex in the open market, in privately negotiated transactions or otherwise, and/or (ii) dispose of all or a portion of the securities or related financial instruments of Imaflex over which he now or hereafter exercises, or may be deemed to exercise, control or direction, or owns.
Additional information is provided in the early warning report filed on www.sedar.com by Mr. Abbandonato pursuant to Regulation 62-103.
SOURCE Imaflex Inc.
More by this Source
Imaflex Inc. announces continued improving results for the quarter ended June 30, 2013
Aug 28, 2013, 13:21 ET
Imaflex grants stock options
Jul 15, 2013, 07:55 ET
Imaflex Appoints Dr. Ralf Dujardin as VP of Marketing & Innovation
Jun 19, 2013, 07:55 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.